Proposed LCDs

When there are Proposed Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Proposed under development, not yet released for comment
C = Proposed LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Proposed LCD Comments to:

Mail:
Noridian Medicare JF Part A
Attention: Proposed LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

X
 
Proposed LCD and LCA Title Release Date of Proposed LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
Colon Capsule Endoscopy (CCE)

Billing and Coding: Colon Capsule Endoscopy (CCE)
08/05/21 09/18/21 F View 11/04/21 View
Micro-Invasive Glaucoma Surgery (MIGS)

Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
05/20/21 07/06/21 F View 08/19/21 View
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer

Billing and Coding: MolDx: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
05/20/21 07/03/21 E      
MolDX: EndoPredict Breast Cancer Gene Expression Test

Billing and Coding: MolDX EndoPredict Breast Cancer Gene Expression Test
05/28/20 07/12/20 A View 05/27/21 View
MolDX: Melanoma Risk Stratification Molecular Testing

Billing and Coding: MolDx: Melanoma Risk Stratification Molecular Testing
05/20/21 07/03/21 E      
MolDX: Minimal Residual Disease Testing for Cancer

Billing and Coding: MolDX: Minimal Residual Disease Testing for Cancer
10/08/20 11/22/20 E      
MolDX: Molecular Testing for Allograft Rejection

Billing and Coding: MolDX: Molecular Testing for Allograft Rejection
05/28/20 07/12/20 A View 05/20/21 View
MolDX: Multiplex Nucleic Acid Amplification Test (NAAT) Panels for Infectious Disease Testing

Billing and Coding: MolDx: Multiplex Nucleic Acid Amplification Test (NAAT) Panels for Infectious Disease Testing
05/20/21 07/03/21 E      
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes

Billing and Coding: MolDx Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes
05/20/21 07/31/21 E      
MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells

Billing and Coding: MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells
05/28/20 07/12/20 A View 05/20/21 View
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
05/28/20 07/12/20 A View 06/10/21 View
Platelet Rich Plasma Injections for Non-Wound Injections

Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
06/24/21 08/04/21 F View 12/09/21 View

 

Last Updated Wed, 19 Jan 2022 17:49:34 +0000